The primary objective of this study is to test a manualized adaptation of positive
psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a
preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and
efficacy of PPT-S over 26 weeks of follow up in comparison to a standard smoking cessation
treatment. Both treatments will be delivered in individual 6 sessions over 6 weeks, and will
include provision of transdermal nicotine patch. The effect size estimates from this Stage 1b
research will provide the foundation for a future application to conduct a large-scale, Stage
II, randomized clinical trial.